The role of Artificial Intelligence in Pharmaceutical Care in Yemen: A Mini Review

Abstract

Artificial Intelligence (AI) is poised to revolutionize pharmaceutical care, particularly in resource-limited settings such as Yemen. This review explores the transformative potential of AI in enhancing pharmacy practices, addressing medication adherence, drug interaction safety, and personalized pharmacotherapy. AI-driven systems can offer customized medication reminders, monitor patient behavior, and identify barriers to adherence, while real-time alerts and complex interaction detection improve drug safety. AI's ability to optimize dosages, monitor therapeutic drug levels, and personalize treatment protocols based on genetic and lifestyle data further enhances therapeutic outcomes. The integration of AI into pharmacogenomics and precision medicine holds promise for tailored drug development and effective therapy. Additionally, AI can support clinical decision-making, optimize inventory and supply chain management, and improve patient education and involvement through customized assistance and symptom monitoring. However, successful implementation in Yemen faces challenges related to data quality, ethical considerations, technological infrastructure, and regulatory frameworks. Addressing these challenges and fostering collaboration among healthcare professionals will be crucial for harnessing AI's full potential to improve pharmaceutical care and patient outcomes in Yemen